Published in Ann Intern Med on September 01, 1986
Longitudinal study of physical ability in the oldest-old. Am J Public Health (1989) 2.78
Making life easier with effort: Basic findings and applied research on response effort. J Appl Behav Anal (1995) 1.93
Assessing the need for health status measures. J Epidemiol Community Health (1993) 1.76
Comparison of subjective ratings of function with observed functional ability of frail older persons. Am J Public Health (1991) 1.47
Development and validation of a printed information brochure for families of chronically critically ill patients. Crit Care Med (2012) 1.43
Movelets: A dictionary of movement. Electron J Stat (2012) 1.29
Assessment of quality of life in small-cell lung cancer using a Daily Diary Card developed by the Medical Research Council Lung Cancer Working Party. Br J Cancer (1991) 1.26
Global Assessment of Functioning (GAF): properties and frontier of current knowledge. Ann Gen Psychiatry (2010) 1.09
Scales for rating motor impairment in Parkinson's disease: studies of reliability and convergent validity. J Neurol Neurosurg Psychiatry (1991) 1.07
Normalization and extraction of interpretable metrics from raw accelerometry data. Biostatistics (2013) 1.06
FRED: an innovative approach to nursing home level-of-care assignments. Health Serv Res (1987) 1.04
Evidence-based guidelines for interpretation of the Panic Disorder Severity Scale. Depress Anxiety (2009) 1.01
An instrument for assessment of subjective visual disability in cataract patients. Br J Ophthalmol (1998) 0.97
A review of functional status measures for workers with upper extremity disorders. Occup Environ Med (2002) 0.97
Assessment of patient and caregiver experiences of dementia-related symptoms: development of the Multidimensional Assessment of Neurodegenerative Symptoms questionnaire. Dement Geriatr Cogn Disord (2009) 0.86
Comparison of EORTC quality of life core questionnaire (EORTC-QLQ-C30) and gastrointestinal quality of life index (GIQLI) in patients undergoing elective colorectal cancer resection. Int J Colorectal Dis (2004) 0.86
Disease, illness and health: theoretical models of the disablement process. Bull World Health Organ (1992) 0.82
Physical diability after retirement and occupational risk factors during working life: a cross sectional epidemiological study in the Paris area. J Epidemiol Community Health (1992) 0.82
Chronic functional somatic symptoms: a single syndrome? Br J Gen Pract (2004) 0.81
Association of measured physical performance and demographic and health characteristics with self-reported physical function: implications for the interpretation of self-reported limitations. Health Qual Life Outcomes (2010) 0.80
Reporting on quality of life in RCTs. CONSORT guidelines should be expanded. BMJ (1999) 0.78
Functional limitations due to axial and peripheral joint impairments in patients with ankylosing spondylitis: are focused measures more informative? Arthritis Care Res (Hoboken) (2013) 0.77
Identification of cut-points in commonly used hip osteoarthritis-related outcome measures that define the patient acceptable symptom state (PASS). Rheumatol Int (2013) 0.77
Assessment of elderly people in hospital. Assessment scales unevaluated. BMJ (1993) 0.75
Validation of the dementia care assessment packet-instrumental activities of daily living. Psychiatry Investig (2013) 0.75
Activities of daily living in Greek cancer patients treated in a palliative care unit. Support Care Cancer (2012) 0.75
A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol (1996) 20.25
Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med (1978) 11.42
A critical appraisal of the quality of quality-of-life measurements. JAMA (1994) 9.10
The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med (1985) 8.55
High agreement but low kappa: II. Resolving the paradoxes. J Clin Epidemiol (1990) 8.28
Clinical biostatistics. LIV. The biostatistics of concordance. Clin Pharmacol Ther (1981) 7.33
Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol (1995) 6.94
The risk of determining risk with multivariable models. Ann Intern Med (1993) 6.45
Variability in radiologists' interpretations of mammograms. N Engl J Med (1994) 5.96
Use of methodological standards in diagnostic test research. Getting better but still not good. JAMA (1995) 5.94
The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest (1984) 5.19
Evaluation of clinical methods for rating dyspnea. Chest (1988) 4.12
Spectrum bias in the evaluation of diagnostic tests: lessons from the rapid dipstick test for urinary tract infection. Ann Intern Med (1992) 3.64
Academic calculations versus clinical judgments: practicing physicians' use of quantitative measures of test accuracy. Am J Med (1998) 3.36
Problems of comorbidity in mortality after prostatectomy. JAMA (1992) 3.27
The International Health Program: the fifteen-year experience with Yale University's Internal Medicine Residency Program. Am J Trop Med Hyg (1999) 3.23
Clinical epidemiological quality in molecular genetic research: the need for methodological standards. JAMA (1999) 3.07
An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use. JAMA (1979) 3.03
The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis (1974) 3.01
The BCG controversy. A methodological and statistical reappraisal. JAMA (1983) 2.60
Clinical biostatistics. XXXVII. Demeaned errors, confidence games, nonplussed minuses, inefficient coefficients, and other statistical disruptions of scientific communication. Clin Pharmacol Ther (1976) 2.53
An analysis of diagnostic reasoning. 3. The construction of clinical algorithms. Yale J Biol Med (1974) 2.44
Context bias. A problem in diagnostic radiology. JAMA (1996) 2.42
The qualification period. J Clin Epidemiol (1991) 2.33
Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy. J Clin Epidemiol (1995) 2.32
A simple procedure for general screening for functional disability in elderly patients. Ann Intern Med (1990) 2.32
Clinical biostatistics. 8. An analytic appraisal of the University Group Diabetes Program (UGDP) study. Clin Pharmacol Ther (1971) 2.28
Claims of equivalence in medical research: are they supported by the evidence? Ann Intern Med (2000) 2.27
Coding ordinal independent variables in multiple regression analyses. Am J Epidemiol (1987) 2.15
A new prognostic staging system for the acquired immunodeficiency syndrome. N Engl J Med (1989) 2.10
Methodologic standards and contradictory results in case-control research. Am J Med (1979) 2.09
Clinical biostatistics. XLIV. A survey of the research architecture used for publications in general medical journals. Clin Pharmacol Ther (1978) 2.07
T. Duckett Jones Memorial Lecture. The Jones criteria and the challenges of clinimetrics. Circulation (1982) 2.06
Clinical biostatistics. XLI. Hard science, soft data, and the challenges of choosing clinical variables in research. Clin Pharmacol Ther (1977) 2.04
The impact of ethnicity, family income, and parental education on children's health and use of health services. Am J Public Health (1999) 2.02
A collection of 56 topics with contradictory results in case-control research. Int J Epidemiol (1988) 2.02
A new clinical prognostic staging system for acute pancreatitis. Am J Med (1993) 2.02
The 'chagrin factor' and qualitative decision analysis. Arch Intern Med (1985) 1.94
Post-menopausal oestrogens protect against fractures of hip and distal radius. A case-control study. Lancet (1979) 1.92
An additional basic science for clinical medicine: II. The limitations of randomized trials. Ann Intern Med (1983) 1.87
Clinical biostatistics. XXV. A survey of the statistical procedures in general medical journals. Clin Pharmacol Ther (1974) 1.87
Double standards, scientific methods, and epidemiologic research. N Engl J Med (1982) 1.81
Clinical biostatistics. XXXIX. The haze of Bayes, the aerial palaces of decision analysis, and the computerized Ouija board. Clin Pharmacol Ther (1977) 1.80
An algorithm for the operational assessment of adverse drug reactions. II. Demonstration of reproducibility and validity. JAMA (1979) 1.65
Indexes and boundaries for "quantitative significance" in statistical decisions. J Clin Epidemiol (1990) 1.63
Measurement of lower limb alignment using long radiographs. J Bone Joint Surg Br (1991) 1.58
Current problems and future challenges in randomized clinical trials. Circulation (1984) 1.57
An analysis of Berkson's bias in case-control studies. J Chronic Dis (1986) 1.53
Clinical biostatistics XXXI. On the sensitivity, specificity, and discrimination of diagnostic tests. Clin Pharmacol Ther (1975) 1.52
Observer variability in the histopathologic diagnosis of lung cancer. Am Rev Respir Dis (1970) 1.51
Complications of peripheral arteriography: a new system to identify patients at increased risk. J Vasc Surg (1995) 1.50
The problems of the "problem-oriented medical record". Ann Intern Med (1973) 1.50
Clinical biostatistics. XX. The epidemiologic trohoc, the ablative risk ratio, and "retrospective" research. Clin Pharmacol Ther (1973) 1.50
The role of diagnostic inconsistency in changing rates of occurrence for coronary heart disease. J Clin Epidemiol (1992) 1.50
On white-coat effects and the electronic monitoring of compliance. Arch Intern Med (1990) 1.48
Joseph Goldberger: an unsung hero of American clinical epidemiology. Ann Intern Med (1994) 1.47
A bibliography of publications on observer variability (final installment). J Clin Epidemiol (1992) 1.47
An analysis of diagnostic reasoning. I. The domains and disorders of clinical macrobiology. Yale J Biol Med (1973) 1.47
Clinical utility of endoscopic retrograde cholangiopancreatography. Gastrointest Endosc (1997) 1.45
Bootstraps and jackknives: new, computer-intensive statistical tools that require no mathematical theories. J Investig Med (1998) 1.43
An additional basic science for clinical medicine: IV. The development of clinimetrics. Ann Intern Med (1983) 1.43
Discontinuation of antistreptococcal prophylaxis. A double-blind study in rheumatic patients free of heart disease. JAMA (1966) 1.42
A critique of methodology in studies of anticoagulant therapy for acute myocardial infarction. N Engl J Med (1969) 1.42
The problem of "protopathic bias" in case-control studies. Am J Med (1980) 1.41
On exorcizing the ghost of Gauss and the curse of Kelvin. MD Comput (1992) 1.39
Does diagnostic accuracy in mammography depend on radiologists' experience? J Womens Health (1998) 1.37
Coffee and pancreatic cancer. The problems of etiologic science and epidemiologic case-control research. JAMA (1981) 1.37
Clinical biostatistics. XXXIV. The other side of 'statistical significance': alpha, beta, delta, and the calculation of sample size. Clin Pharmacol Ther (1975) 1.36
The 'epidemiologic necropsy'. Unexpected detections, demographic selections, and changing rates of lung cancer. JAMA (1987) 1.35
Scientific problems in clinical scales, as demonstrated in the Karnofsky index of performance status. J Chronic Dis (1979) 1.34
New epidemiologic evidence confirming that bias does not explain the aspirin/Reye's syndrome association. JAMA (1989) 1.34
Clinical symptoms and comorbidity: significance for the prognostic classification of cancer. Cancer (1996) 1.31
Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway disease. Am Rev Respir Dis (1985) 1.30
An additional basic science for clinical medicine: I. The constraining fundamental paradigms. Ann Intern Med (1983) 1.29
Clinical effects of recurrent attacks of acute rheumatic fever: a prospective epidemiologic study of 105 episodes. J Chronic Dis (1967) 1.28
Monte Carlo methods in clinical research: applications in multivariable analysis. J Investig Med (1997) 1.28
Operational criteria for adverse drug reactions in evaluating suspected toxicity of a popular scabicide. Clin Pharmacol Ther (1980) 1.27
Clinical biostatistics. XXVII. The derangements of the 'range of normal'. Clin Pharmacol Ther (1974) 1.27
Clinical biostatistics. II. Statistics versus science in design of experiments. Clin Pharmacol Ther (1970) 1.27
Clinical biostatistics. 28. The biostatistical problems of pharmaceutical surveillance. Clin Pharmacol Ther (1974) 1.26
What kind of basic science for clinical medicine? N Engl J Med (1970) 1.25
Alternative analytic methods for case-control studies of estrogens and endometrial cancer. N Engl J Med (1978) 1.25
Ask patients what they want. Evaluation of individual complaints before total hip replacement. J Bone Joint Surg Br (1994) 1.23
Invidious comparisons and unmet clinical challenges. Am J Med (1992) 1.22
Necropsy evidence of detection bias in the diagnosis of lung cancer. Arch Intern Med (1986) 1.21
The need for humanised science in evaluating medication. Lancet (1972) 1.21
Risk for systemic embolization of atrial fibrillation without mitral stenosis. Am J Cardiol (1990) 1.20
Symptoms as an index of biological behaviour and prognosis in human cancer. Nature (1966) 1.20
The impact of clinical history on mammographic interpretations. JAMA (1997) 1.17
The role of tonsils in predisposing to streptococcal infections and recurrences of rheumatic fever. N Engl J Med (1970) 1.17